Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1996 2
1997 3
1999 6
2000 2
2001 5
2002 8
2003 5
2004 10
2005 5
2006 4
2007 10
2008 9
2009 7
2010 11
2011 6
2012 7
2013 3
2014 6
2015 2
2016 1
2017 1
2020 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 19117692

103 results
Results by year
Filters applied: . Clear all
Page 1
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.
Citrin D, Mansueti J, Likhacheva A, Sciuto L, Albert PS, Rudy SF, Cooley-Zgela T, Cotrim A, Solomon B, Colevas AD, Russo A, Morris JC, Herscher L, Smith S, Van Waes C. Citrin D, et al. Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1040-6. doi: 10.1016/j.ijrobp.2008.09.053. Epub 2008 Dec 29. Int J Radiat Oncol Biol Phys. 2009. PMID: 19117692 Free PMC article.
Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
Abitbol A, Abdel-Wahab M, Lewin A, Troner M, Rodrigues MA, Hamilton-Nelson KL, Markoe A. Abitbol A, et al. Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):942-7. doi: 10.1016/s0360-3016(02)02816-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12095561 Clinical Trial.
The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M, Jaboin J, Taylor R, Wolf J, Banglore M, Van Echo D, Ord R. Suntharalingam M, et al. Semin Oncol. 2004 Dec;31(6 Suppl 18):2-7. doi: 10.1053/j.seminoncol.2005.02.001. Semin Oncol. 2004. PMID: 15726515 Clinical Trial.
Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck.
Rosenthal DI, Lee JH, Sinard R, Yardley DA, Machtay M, Rosen DM, Egorin MJ, Weber RS, Weinstein GS, Chalian AA, Miller LK, Frenkel EP, Carbone DP. Rosenthal DI, et al. J Clin Oncol. 2001 Mar 1;19(5):1363-73. doi: 10.1200/JCO.2001.19.5.1363. J Clin Oncol. 2001. PMID: 11230480 Clinical Trial.
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).
Fury MG, Sherman EJ, Rao SS, Wolden S, Smith-Marrone S, Mueller B, Ng KK, Dutta PR, Gelblum DY, Lee JL, Shen R, Kurz S, Katabi N, Haque S, Lee NY, Pfister DG. Fury MG, et al. Ann Oncol. 2014 Mar;25(3):689-694. doi: 10.1093/annonc/mdt579. Epub 2014 Feb 3. Ann Oncol. 2014. PMID: 24496920 Free PMC article. Clinical Trial.
103 results